Glazer Capital LLC’s Verona Pharma VRNA Stock Holding History

Glazer Capital LLC’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,205,878	Closed	-$342M	–	409
2025 Q3	$342M	Buy	+3,205,878	New	+$335M	11.48%	1

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Glazer Capital LLC's VRNA Position: Q4 2025 in Review

Glazer Capital LLC sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 3,205,878 shares — an estimated $342M sold.

Glazer Capital LLC first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $342M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Glazer Capital LLC reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Glazer Capital LLC sold 3,205,878 Verona Pharma shares in Q4 2025, an estimated $342M.
Glazer Capital LLC first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Glazer Capital LLC's Verona Pharma position peaked at $342M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Glazer Capital LLC's 13F filing for Q4 2025, filed 13 Feb 2026.